Use of the RAPDx device to evaluate efficacy of treatment in patients with optic nerve disease
1 October 2018
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Detection rate, optic nerve disease, relative afferent pupillary defect, standard values
The RAPDx objectively determines the RAPD magnitude by alternately presenting light stimuli to each eye and deriving amplitude and latency scores. The authors of this paper evaluated the amplitude and latency scores from the RAPDx together with other ophthalmic investigations...
Use of RAPDx device with optic nerve disease
1 August 2016
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Detection rate, optic nerve disease, relative afferent pupillary defect, standard values
The authors have previously reported on use of the RAPDx device for evaluating relative afferent pupillary defects (RAPD). RAPDx objectively determines the magnitude of RAPD by presenting light stimuli alternately to pairs of eyes with laterality. The parameters of amplitude...
